Search - tctmd.com

Displaying 581 - 600 of 788

Sort: Relevancy | Date

News Conference News TCT 2012

Biomarkers May Identify Risky Subcritical Lesions

October 30, 2012

Presentation TCT 2012

Case 2: Patient with Stable Class 3 Angina, Triple-Vessel CAD, and Intermediate Syntax and STS Scores(2)

Presenter: Megan Coylewright

October 26, 2012

Presentation TCT 2012

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis

Presenter: Megan Coylewright

October 26, 2012

Presentation TCT 2012

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis(2)

Presenter: Megan Coylewright

October 26, 2012

News Industry News

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

October 26, 2012

News Conference News TCT 2012

No Excess Bleeding with EES vs. BMS in Octogenarians Despite Prolonged DAPT

October 26, 2012

News Conference News TCT 2012

Future Looks Bright for Stem Cell-Based Myocardial Therapy

October 26, 2012

News Conference News TCT 2012

Debate Continues with the AUC

October 26, 2012

Presentation TCT 2012

Case 2: Patient with Stable Class 3 Angina, Triple-Vessel CAD, and Intermediate Syntax and STS Scores

Presenter: Megan Coylewright

October 26, 2012

News Conference News TCT 2012

TRILOGY ACS Substudy: Angiography Prior to Prasugrel Therapy Reduces CV Events

October 25, 2012

News Industry News

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

October 24, 2012

News Conference News TCT 2012

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

October 24, 2012

News Conference News TCT 2012

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

October 24, 2012

News Industry News

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

October 24, 2012

News Conference News TCT 2012

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

October 24, 2012

News Industry News

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

October 24, 2012

News Daily News

Una Encuesta de la SCAI y un Comunicado de Consenso llaman la Atención sobre la Calidad de Vida

Caitlin E. Cox

October 23, 2012

News Daily News

SCAI Survey, Consensus Statement Draw Attention to Quality of Life

Caitlin E. Cox

October 23, 2012

News Industry News

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

October 23, 2012

News Industry News

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

October 23, 2012

Advertisement

Biomarkers May Identify Risky Subcritical Lesions

Case 2: Patient with Stable Class 3 Angina, Triple-Vessel CAD, and Intermediate Syntax and STS Scores(2)

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis

Case 1: Patient with Stable Class 1 Angina Treated with Aspirin and Statin and a Mid LAD 70% Stenosis(2)

Study Finds Drug-Eluting Stents Exhibit Some Benefits Over Bare-Metal Stents In Patients Over 80, Though Both Demonstrate Clinical Benefit

No Excess Bleeding with EES vs. BMS in Octogenarians Despite Prolonged DAPT

Future Looks Bright for Stem Cell-Based Myocardial Therapy

Debate Continues with the AUC

Case 2: Patient with Stable Class 3 Angina, Triple-Vessel CAD, and Intermediate Syntax and STS Scores

TRILOGY ACS Substudy: Angiography Prior to Prasugrel Therapy Reduces CV Events

Study Finds That Prasugrel May Reduce Cardiovascular Events Among Patients Managed Medically After an Angiogram for Acute Coronary Syndrome

Pre-PCI Statin Regimen Produces No Significant Effect on Troponin I Release

PEACE: Data Demonstrate Benefits of Plaque Identification in High-Risk Patients

FFR-Guided PCI Demonstrates Cost-Effectiveness When Compared to Medical Therapy for Stable Coronary Artery Disease

FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy

Data from FAME II Trial Concludes FFR-Guided PCI is Cost Effective and Improves Patient Outcomes

Una Encuesta de la SCAI y un Comunicado de Consenso llaman la Atención sobre la Calidad de Vida

SCAI Survey, Consensus Statement Draw Attention to Quality of Life

New Retrospective Studies of Hospital Readmission Rates for Subsequent Heart Attack and Initial Hospitalization Costs in ACS-PCI Patients Treated with Effient® (Prasugrel) or Plavix® (Clopidogrel) Pre

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content